Score 4.4. Cullinan, FLT3 × CD3 in R/R AML. Not partnered.
Score 4.4. invoX Pharma, PD-L1 × 4-1BB in melanoma. No partner found.
Score 4.2. Excelmab, CD20 × CD3 in B-cell lymphoma. Seeking partners.
Score 4.1. Aptevo, CD123 × CD3 in 1L AML. No deal found.
Score 4.0. Crescendo, PSMA × 4-1BB in prostate cancer. No deal found.
Score 4.0. Janux, PSMA × CD3 in prostate cancer. No deal found.